AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses

Summary

Researchers are evaluating the safety of allogeneic Adipose Derived Mesenchymal Stem Cells (AMSC) use during hemodialysis arteriovenous fistula and arterial bypass creation and its efficacy on improving access maturation and primary anastomotic patency.

Timeline

Start

2020-05-15

Primary completion

2026-12

Completion

2027-06

Drugs

Indications